Marginal Zone Lymphomas
4 clinical trials · Condition
◉ Watch Marginal Zone Lymphomas
| Record | Firm | Date |
|---|---|---|
| ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies (NCT02362035) | Acerta Pharma BV | 2015-02-20 |
| Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas (NCT00877214) | Jurgen Barth | 2009-04-01 |
| Bendamustine Plus Rituximab Versus CHOP Plus Rituximab (NCT00991211) | University of Giessen | 2004-01-01 |
Track Marginal Zone Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.